Watch Demo

2021 Global Hematology and Flow Cytometry Database and Analysis for the US, Europe, Japan

2021 Global Hematology and Flow Cytometry Database and Analysis for the US, Europe, Japan
  • Publish Date:May 2021

  • Report ID:6076297

  • Format:PDF

  • Publisher:Venture Planning Group

$ 14500

Summary

2021 Global Hematology and Flow Cytometry Database and Analysis for the US, Europe, Japan: Analyzers and Reagents, Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Competitive Landscape, Emerging Technologies, Latest Instrumentation, Growth Opportunities

This unique report provides information and analysis not available from any other published source.

This comprehensive seven-country report contains 700 pages, 250 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the global hematology and flow cytometry markets during the next five years.

The report is available by section, and can be customized to specific information needs and budget.

The report explores business and technological trends in the US, Europe (France, Germany, Italy, Spain, UK) and Japan provides market share estimates, test volume forecasts, and instrument placements; compares features of major analyzers; profiles leading competitors and emerging market entrants; and suggests specific product and marketing opportunities facing suppliers.

Rationale

During the next five years, continued advances in molecular diagnostics, monoclonal antibodies, lasers and IT, as well as growing understanding of immunologic forces regulating systemic diseases, will have a profound impact on the hematology and flow cytometry markets worldwide. New molecular diagnostic and monoclonal antibody tests will facilitate existing procedures and provide basis for sensitive, specific and simple assays. The introduction of smaller and easy-to-operate laser systems will further expand applications of flow cytometry to routine clinical laboratories. Further advances in IT will reduce the cost of instrument manufacture, service warranty, and permit development of self-troubleshooting, autocalibration and other advanced features. Presently tedious analyses of chromosomal abnormalities, DNA content, and lymphocyte subsets will become more automated and routine.

Hematology Tests

CBC + 5-Part Differential, Manual Differential/Review, Hematocrit (Automated, Manual),
Hemoglobin (Automated, Manual), Sedimentation Rate, Reticulocytes, WBC (Automated, Manual),
Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils.

Flow Cytometry Tests

Cell Surface Markers (CD4/CD8/TandB Lymphocytes, CD34, Others), Chemotherapy Monitoring (Leukemia/Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analysis, Granulocyte Function, Receptor DNA/RNA Analysis, Cell Culturing.

Sales and Market Share Analysis

- Sales and market shares of major
instrument and reagent suppliers.

Geographic Coverage

France, Germany, Italy, Japan, Spain, UK, USA

Competitive Assessments

- Extensive strategic profiles of
major suppliers and emerging market entrants.

Market Segmentation Analysis

- Sales and market share estimates for leading suppliers of hematology and flow cytometry products by country.

- Test and sales forecasts for over 40 procedures
by country, individual test and market segment:

     - Hospitals
     - Commercial/Private Laboratories
     - Ambulatory Care Centers
     - Physician Offices/Group Practices

Current and Emerging Products

- Analysis of current and emerging hematology and flow cytometry tests
- Reagent and instrument sales forecasts by market segment
- Instrument placements and installed base by manufacturer and model
- Sales and market shares of reagent and instrument suppliers

Technology Review

- Assessment of current and emerging
  technologies, and their potential  market applications.

- Comprehensive lists of companies developing
or marketing new technologies and products by test.

Worldwide Market Overview

- Facilities performing hematology and flow cytometry
testing by country.

- Test volume and sales projections by country.

Strategic Recommendations

- New product development opportunities
with significant market appeal.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Contains 700 pages and 250 tables



Companies Profiled

Competitive Assessments

- Abbott
- Agilent Technologies
- Beckman Coulter/Danaher
- Becton Dickinson
- Bio-Rad
- CellaVision
- Horiba
- Nihon Kohden
- Ortho-Clinical Diagnostics
- Roche
- Siemens Healthineers
- Sysmex

Table of contents

Methodology

Our market research methodology is designed to provide the clients with comprehensive and accurate information on various industries and markets. It includes data collection, primary interviews, macro-economic factor analysis, country-level data analysis etc.

The data is gathered from a wide range of sources, including industry reports, government statistics, and company financials. This data is then analyzed and cross-referenced to ensure its accuracy and reliability. Next, primary interviews are conducted with industry experts and key stakeholders to gather their insights and perspectives on the market. This information is then combined with the data collected to provide a complete picture of the market. Macro-economic factor analysis is also carried out to understand the impact of external factors on the market. Finally, country-level data analysis is performed to understand the market dynamics in specific regions and countries.

Reportlinker's market research methodology is designed to provide clients with a clear understanding of the market, its trends, and its future potential.